Regenerative potential of prostate luminal cells revealed by single-cell analysis.
Wouter R KarthausMatan HofreeDanielle ChoiEliot L LintonMesruh TurkekulAlborz BejnoodBrett CarverAnuradha GopalanWassim AbidaVincent LaudoneMoshe BitonOjasvi ChaudharyTianhao XuIgnas MasilionisKatia ManovaLinas MazutisDana Pe'erAviv RegevCharles L SawyersPublished in: Science (New York, N.Y.) (2020)
Androgen deprivation is the cornerstone of prostate cancer treatment. It results in involution of the normal gland to ~90% of its original size because of the loss of luminal cells. The prostate regenerates when androgen is restored, a process postulated to involve stem cells. Using single-cell RNA sequencing, we identified a rare luminal population in the mouse prostate that expresses stemlike genes (Sca1 + and Psca +) and a large population of differentiated cells (Nkx3.1 +, Pbsn +). In organoids and in mice, both populations contribute equally to prostate regeneration, partly through androgen-driven expression of growth factors (Nrg2, Rspo3) by mesenchymal cells acting in a paracrine fashion on luminal cells. Analysis of human prostate tissue revealed similar differentiated and stemlike luminal subpopulations that likewise acquire enhanced regenerative potential after androgen ablation. We propose that prostate regeneration is driven by nearly all persisting luminal cells, not just by rare stem cells.
Keyphrases
- stem cells
- induced apoptosis
- prostate cancer
- single cell
- cell cycle arrest
- benign prostatic hyperplasia
- endoplasmic reticulum stress
- signaling pathway
- endothelial cells
- cell death
- oxidative stress
- poor prognosis
- gene expression
- mesenchymal stem cells
- metabolic syndrome
- risk assessment
- high throughput
- atrial fibrillation
- wound healing
- skeletal muscle
- binding protein
- dna methylation